These macrophages are recruited and polarized into a pro-tumoral phenotype (upregulation of CD206, CD163 and CD209) by CSF-1, CXCL2, VEGFA and CCL18 produced by cancer cells (24). The gene discussed is CD163; the disease is cancer.